v3.24.2.u1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets: Ìý Ìý
Cash and cash equivalents $ 40,576 $ 95,881
Accounts receivable, net 105,313 123,379
Inventory, net 60,153 65,697
Other current assets and prepaid expenses 32,288 24,519
Assets held for sale 119,651 0
Total current assets 357,981 309,476
Property, plant and equipment, net 66,766 75,429
Intangible assets, net 659,111 740,283
In-process research and development 195,000 195,000
Goodwill 530,106 598,260
Investments 101,489 16,082
Operating lease right-of-use assets 61,622 68,088
Other assets 7,796 9,080
Total assets 1,979,871 2,011,698
Current liabilities: Ìý Ìý
Accounts payable 82,242 69,677
Accrued expenses 94,516 90,086
Current maturities of operating leases 11,624 12,996
Current portion of convertible notes 170 0
Current portion of lines of credit and notes payable 22,129 27,293
Liabilities associated with assets held for sale 8,872 0
Total current liabilities 219,553 200,052
Operating lease liabilities 49,624 54,140
Long term portion of convertible notes 175,942 214,325
Deferred tax liabilities 119,120 126,773
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit 20,315 27,189
Total long-term liabilities 365,001 422,427
Total liabilities 584,554 622,479
Equity: Ìý Ìý
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 727,176,232 and 781,936,885 shares issued at June 30, 2024 and December 31, 2023, respectively 7,273 7,820
Treasury Stock - 29,800,177, and 8,655,082 shares at June 30, 2024 and December 31, 2023, respectively (1,791) (1,791)
Additional paid-in capital 3,540,414 3,433,006
Accumulated other comprehensive loss (46,652) (38,030)
Accumulated deficit (2,103,927) (2,011,786)
Total shareholders’ equity 1,395,317 1,389,219
Total liabilities and equity $ 1,979,871 $ 2,011,698

Source